A significant decrease in isoprostane was observed in the patients with high baseline levels ( Figure 2C ); when subgrouping patients into obese and nonobese, the decrease in the obese group was statistically significant, but the decrease in the nonobese patients did not reach statistical significance ( Figure 2F ).
← all excerpts
Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation.
1
—
—